COVID-19 quick takes—part two
Lockdowns and vaccines

COVID-19 quick takes--part three

Three-39116_640

This HND piece continues on from the previous week, this time looking at a ridiculous mask study from the CDC; Pfizer deciding not to pursue the India market for its vaccine; and the WHO inspection of the Wuhan Lab.

We reveal a serious issue with that CDC, that is hiding in plain site, and was missed by almost every single media outlet that covered it. One has to wonder why Pfizer would bail on the world's second most populated country, to sell more of its vaccines. And as to the WHO inspection, let's just say that it was...flawed.

Read the complete article.

Comments

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)